Quebec, Qc, January 9th, 2014 – FISO Technologies, a leading manufacturer of high-quality fiber optic sensors and signal conditioners, wholly owned subsidiary of Nova Metrix LLC, has wind in its sails. 2013 has been a great year for the company and 2014 looks even more promising, especially in the life sciences market, where the last few months have been very active and prosperous.
Having acquired certain assets, including intellectual property assets, of Samba Sensors, a company formerly headquartered in Sweden that designed and manufactured fiber optic pressure transducers for the preclinical, clinical and industrial markets, FISO has successfully broadened its sensing and monitoring offering and was able to further position itself as a leader in the life sciences market. Offering products with a faster acquisition rate than the competition as well as extremely small and precise -yet robust- sensors, FISO remains the synonym of a state-of-the-art technology that has been proven reliable many times over.
Already active in the life sciences market, the company made significant important moves in 2013, particularly in the research part of this market. In order to do so, FISO officially licensed LMS Corporation (Japan) and Harvard Apparatus (Europe and America) for the distribution of its products. FISO’s technology, when put together with its clients’, is able to make a great impact in research for adequate treatment of many degenerative and incurable diseases. Research labs and governmental institutes need cutting-edge products that will enable them to further advance their works, thus change the lives of many people, and that is where FISO plays its role.
“It is rewarding to be able to be part of such important processes, to see that our technology can have a concrete and direct impact on really important, even life-altering, matters” said Maxim Vachon-Savary, Product Line Manager for FISO Technologies. “Many deliveries of our systems have already been completed to a great number of research labs and national institutes all over the USA, Japan as well as in Europe” adds Mr Vachon-Savary. “The coming year will for sure be busy for us, and we are looking forward to working with our clients into coming up with solutions perfectly suited for their needs” said Frederic Borne, General Manager.
FISO Technologies Inc., a wholly owned subsidiary of Nova Metrix LLC, is pleased to announce that it has doubled the size of its manufacturing cleanrooms and is commissioning additional automated assembly stations. “The company has made this investment in response to the rapid growth it has experienced over the last several years and in furtherance of its commitment to maintaining state-of-the art manufacturing facilities to serve the medical, process control, energy, and defense markets,” said Frederic Borne, General Manager for FISO.
Quebec City, Quebec, December 28, 2012 – FISO Technologies, Inc., a wholly owned subsidiary of Nova Metrix LLC, is pleased to announce that it has acquired certain assets, including intellectual property assets, of Samba Sensors AB (http://www.sambasensors.com), formerly headquartered in Sweden. Samba Sensors designs, manufactures, and sells Fiber Optic pressure transducers for both the preclinical, clinical and industrial markets. “We are very pleased to add the Samba brand and its technology to our portfolio and believe it will further enhance our global position in the fiber optic point sensor market,” said Fred Borne, General Manager of FISO Technologies, Inc. “By adding these assets of Samba Sensors to our business, we are broadening our sensing and monitoring offerings to our customers’ increasingly demanding applications,” commented Jeffrey Cohen, President of Nova Metrix LLC.
Quebec, Quebec, December 1st , 2011 - FISO Technologies, leading manufacturer of high-quality fiber optic sensors and signal conditioners, has completed the delivery of 600 fiber optic temperature probes to a major medical device manufacturer. Pre-assembled by FISO on a specialty cable, the probes are part of a next generation of ablation devices for oncology treatment. Over multiple prototype runs in animal studies, FISO’s temperature probes demonstrated their reliability. The probes, once Gamma sterilized and fully integrated into ablation needles, were precise, accurate and reliable.